It has been a mixed year for Galectin Therapeutics Inc insiders: $65,000 bought by two people and $7 million sold by seven, so more selling than buying overall.
FREEMAN KEVIN D (Director) made the biggest buy, worth around $20,000.
On the institutional side, 98 funds reported holding GALT at the end of Q2 2026, and more funds bought than sold. 5 quarters in a row of net selling by insiders. Insiders bought in 3 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 16, 2026 | Jamil Khurram | Executive Officer | Sell | 16,250 | $5.13 | $83K | SEC |
| Jun 30, 2026 | Shlevin Harold H. | Director | Sell | 22,268 | $5.04 | $112K | SEC |
| Jun 30, 2026 | Shlevin Harold H. | Director | Sell | 7,732 | $5.00 | $39K | SEC |
| Jun 30, 2026 | Jamil Khurram | Executive Officer | Sell | 2,037 | $5.00 | $10K | SEC |
| Jun 30, 2026 | Jamil Khurram | Executive Officer | Sell | 47,467 | $5.04 | $239K | SEC |
| Jun 30, 2026 | Jamil Khurram | Executive Officer | Sell | 2,533 | $5.00 | $13K | SEC |
| Jun 25, 2026 | Jamil Khurram | Executive Officer | Sell | 7,557 | $3.14 | $24K | SEC |
| May 28, 2026 | Jamil Khurram | Executive Officer | Sell | 568 | $3.10 | $2K | SEC |
| Feb 9, 2026 | ELDRED KARY | Director | Buy | 300 | $2.70 | $810 | SEC |
| Jan 6, 2026 | LEWIS JOEL | CEO | Sell | 37,698 | $3.58 | $135K | SEC |
| Jan 6, 2026 | LEWIS JOEL | CEO | Sell | 18,571 | $4.20 | $78K | SEC |
| Jan 6, 2026 | CALLICUTT JACK W | CFO | Sell | 20,354 | $3.67 | $75K | SEC |
| Jan 6, 2026 | CALLICUTT JACK W | CFO | Sell | 25,732 | $3.90 | $100K | SEC |
| Jan 6, 2026 | CALLICUTT JACK W | CFO | Sell | 13,914 | $4.20 | $58K | SEC |
| Jan 6, 2026 | Jamil Khurram | Executive Officer | Sell | 21,446 | $3.65 | $78K | SEC |
In the last 12 months Galectin Therapeutics Inc insiders made open-market purchases worth about $65,000 and sales worth about $7 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in GALT was filed on 2026-07-16.
98 investment managers reported holding GALT in SEC Form 13F filings for Q2 2026.
No congressional trades in GALT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).